Such findings might explain B16-F1 melanoma outgrowth in the face of the functional anti-tumor CD8+ T cell responses that are elicited against this tumor in early stages of its growth (9), and subsequent tumor progression could then be compounded by the overexpression of genes with active immunosuppressive functions as described above. The gene discussed is CD8A; the disease is melanoma.